IDNA holdings
All 63 positions of iShares Genomics Immunology and Healthcare ETF.
Positions
63
Top 10 weight
48.1%
Effective holdings
24.1
1 / sum of squared weights
In stocks
99.7%
In bonds
0.0%
Outside the US
31.8%
Asset mix
Sectors
87% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | MRNAModerna, Inc. Common Stock | Equity | 12.11% | $37M | 187,809 | US |
| 2 | TWSTTwist Bioscience Corporation Common Stock | Equity | 6.40% | $20M | 128,701 | US |
| 3 | IOVAIovance Biotherapeutics, Inc. Common Stock | Equity | 4.72% | $14M | 1,084,386 | US |
| 4 | GMABGenmab A/S ADS | Equity | 4.18% | $13M | 36,127 | DK |
| 5 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 3.67% | $11M | 59,680 | US |
| 6 | TAKEDA PHARMACEUTICAL | Equity | 3.48% | $11M | 289,700 | JP |
| 7 | MRKMerck & Co., Inc. | Equity | 3.44% | $11M | 73,760 | US |
| 8 | IBRXImmunityBio, Inc. Common Stock | Equity | 3.41% | $10M | 1,052,633 | US |
| 9 | REGNRegeneron Pharmaceuticals Inc | Equity | 3.39% | $10M | 14,015 | US |
| 10 | BAYNBAYER AG | Equity | 3.33% | $10M | 213,176 | DE |
| 11 | VRTXVertex Pharmaceuticals Inc | Equity | 3.28% | $10M | 19,935 | US |
| 12 | EXELExelixis Inc | Equity | 3.26% | $10.0M | 169,083 | US |
| 13 | INCYIncyte Genomics Inc | Equity | 3.21% | $9.8M | 87,018 | US |
| 14 | CAICaris Life Sciences, Inc. Common Stock | Equity | 3.08% | $9.4M | 342,805 | US |
| 15 | BNTXBioNTech SE American Depositary Share | Equity | 3.05% | $9.3M | 101,150 | DE |
| 16 | ROPRoper Technologies, Inc. Common Stock | Equity | 3.00% | $9.2M | 21,624 | CH |
| 17 | IDYAIDEAYA Biosciences, Inc. Common Stock | Equity | 2.74% | $8.4M | 232,469 | US |
| 18 | GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | Equity | 2.58% | $7.9M | 343,476 | GB |
| 19 | ABCLAbCellera Biologics Inc. Common Shares | Equity | 2.58% | $7.9M | 655,577 | CA |
| 20 | SANBanco Santander S.A. | Equity | 2.57% | $7.9M | 98,888 | FR |
| 21 | IPNIPSEN SA | Equity | 2.53% | $7.7M | 48,842 | FR |
| 22 | RCUSArcus Biosciences, Inc. | Equity | 1.83% | $5.6M | 234,123 | US |
| 23 | NVAXNovavax Inc | Equity | 1.58% | $4.8M | 437,495 | US |
| 24 | ONO PHARMACEUTICAL | Equity | 1.45% | $4.4M | 312,500 | JP |
| 25 | VIRVir Biotechnology, Inc. Common Stock | Equity | 1.36% | $4.1M | 372,599 | US |
| 26 | CRSPCRISPR Therapeutics AG | Equity | 1.32% | $4.0M | 80,165 | US |
| 27 | NUVBNuvation Bio Inc. | Equity | 1.12% | $3.4M | 690,777 | US |
| 28 | JANXJanux Therapeutics, Inc. Common Stock | Equity | 0.97% | $3.0M | 159,934 | US |
| 29 | PSNLPersonalis, Inc. Common Stock | Equity | 0.91% | $2.8M | 173,205 | US |
| 30 | KURAKura Oncology, Inc. | Equity | 0.83% | $2.5M | 240,168 | US |
| 31 | RIGLRigel Pharmaceuticals Inc. (New) | Equity | 0.80% | $2.4M | 49,959 | US |
| 32 | SUNSHINE LAKE PHARMA LTD CLASS H | Equity | 0.76% | $2.3M | 450,100 | CN |
| 33 | GENFLEET THERAPEUTICS (SHANGHAI) I | Equity | 0.63% | $1.9M | 534,800 | CN |
| 34 | VSTMVerastem, Inc. | Equity | 0.61% | $1.9M | 230,195 | US |
| 35 | PACBPacific Biosciences of California, Inc. | Equity | 0.60% | $1.8M | 801,262 | US |
| 36 | CRVSCorvus Pharmaceuticals, Inc. | Equity | 0.59% | $1.8M | 176,573 | US |
| 37 | ALVOAlvotech Ordinary Shares | Equity | 0.59% | $1.8M | 315,450 | IS |
| 38 | XNCRXencor, Inc. | Equity | 0.50% | $1.5M | 62,679 | US |
| 39 | NTLAIntellia Therapeutics, Inc | Equity | 0.49% | $1.5M | 118,340 | US |
| 40 | DNAGinkgo Bioworks Holdings, Inc. | Equity | 0.48% | $1.5M | 130,496 | US |
| 41 | VLAVALNEVA | Equity | 0.41% | $1.3M | 449,845 | FR |
| 42 | DSGNDesign Therapeutics, Inc. Common Stock | Equity | 0.40% | $1.2M | 105,370 | US |
| 43 | CTMXCytomX Therapeutics, Inc. | Equity | 0.39% | $1.2M | 484,198 | US |
| 44 | SHANGHAI HENLIUS BIOTECH H | Equity | 0.37% | $1.1M | 173,300 | CN |
| 45 | OCGNOcugen, Inc. Common Stock | Equity | 0.30% | $911K | 932,305 | US |
| 46 | ABCLON INC | Equity | 0.28% | $844K | 44,179 | KR |
| 47 | XTSLABLK CSH FND TREASURY SL AGENCY | Cash | 0.18% | $552K | 552,240 | US |
| 48 | PRMEPrime Medicine, Inc. Common Stock | Equity | 0.10% | $302K | 84,316 | US |
| 49 | JPYLazard Japanese Equity ETF | Cash | 0.07% | $218K | 34,420,985 | JP |
| 50 | GBPGBP CASH | Cash | 0.04% | $119K | 90,166 | GB |
| 51 | HBCFTCASH COLLATERAL USD HBCFT | Cash | 0.02% | $48K | 48,000 | GB |
| 52 | CHFCHF CASH | Cash | 0.01% | $40K | 32,986 | CH |
| 53 | USDProShares Ultra Semiconductors | Cash | 0.01% | $33K | 33,499 | US |
| 54 | DKKDKK CASH | Cash | 0.00% | $13K | 88,953 | DK |
| 55 | ARCELLX INC CVR | Equity | 0.00% | $5K | 73,059 | US |
| 56 | HKDAMTD Digital Inc. American Depositary Shares (every five of which represent two Class A Ordinary Shares) | Cash | 0.00% | $4K | 28,855 | HK |
| 57 | KRWKRW CASH | Cash | 0.00% | $3K | 4,226,072 | KR |
| 58 | EUREUR CASH | Cash | 0.00% | $751 | 670 | EU |
| 59 | TWDTWD CASH | Cash | 0.00% | $164 | 5,229 | TW |
| 60 | KRWKRW/USD | Cash | 0.00% | −$3 | 7,778,229 | US |
| 61 | OMNIAB INC $12.50 VESTING Prvt | Equity | 0.00% | $0 | 19,498 | US |
| 62 | OMNIAB INC $15.00 VESTING Prvt | Equity | 0.00% | $0 | 19,498 | US |
| 63 | IXCZ6E-MINI HEALTH CARE SECTOR DEC 26 | Derivative | 0.00% | $0 | 5 |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Exit | Roche Holding AG | 4.35% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | Roche Holding AG | — | 3.99% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.